KD and KB are capable to increase mitochondrial respiration via an increase in ATP production and improve the efficiency of the mitochondrial respiratory chain complex with increased mitochondrial biogenesis (69)
The FDA position In January of a recent evaluation cycle, the FDA conducted a preliminary assessment of GLP-1 receptor agonists and psychiatric side effects
doi: 10.1158/0008-5472.CAN-13-1865 149 BullmanSPedamalluCSSicinskaEClancyTEZhangXCaiDet al
Personalized, Monitored Care Every patient begins with a medical consultation and lab work to evaluate vitamin levels, metabolic health, and hormone balance
For others, the theoretical risk appears to remain very low based on 23 years of clinical evidence, but patients considering therapy beyond 5 years should discuss ongoing monitoring and emerging safety data with their provider
Naltrexone/Bupropion ER (Contrave): Newly Approved Treatment Option for Chronic Weight Management in Obese Adults